Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914062-13-000107
Filing Date
2013-03-11
Accepted
2013-03-11 17:22:40
Documents
1
Period of Report
2013-03-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6463
  Complete submission text file 0000914062-13-000107.txt   7892
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 63 LOVELACE DRIVE WEST HARTFORD CT 06117
Business Address
ROME JERALD K (Reporting) CIK: 0001285677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 13681774